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PDGF initiates two distinct phases of protein kinase C activity
that make unequal contributions to the G0 to S transition
Egle Balciunaite*†, Steven Jones*, Alex Toker‡ and Andrius Kazlauskas*
Background: Platelet-derived growth factor (PDGF) promotes cell-cycle
progression by engaging signaling enzymes such as phospholipase Cγ (PLCγ).
When activated, PLCγ cleaves phosphatidylinositol-4,5-bisphosphate to
produce inositol-1,4,5-trisphosphate (IP3) and diacylglycerol (DAG). IP3
stimulates the release of calcium from intracellular stores, which together with
DAG activate some protein kinase C (PKC) family members. In this study we
focused on putative downstream effectors of PLCγ − PKC family members. We
investigated whether, and when, DAG-responsive PKCs contribute to PDGF-
dependent DNA synthesis.
Results: In HepG2 cells expressing wild-type PDGF β receptors (βPDGFRs),
PDGF activated at least one PKC family member (PKCε) at two distinct
times — within 10 minutes after PDGF stimulation, and then for a longer duration
between 5 and 9 hours. Blocking the early burst of PKC activity had no effect
on PDGF-dependent DNA synthesis. In contrast, the DNA-synthesis response
was reduced by 60–80% when the second phase of PKC activity was blocked.
Similarly, DAG rescued PDGF-dependent DNA synthesis in the cells
expressing a mitogenically incompetent mutant βPDGFR, but only when DAG
was added at times corresponding to the late phase of PKC activity. Our
studies also indicate that the late phase of PKCε activity can be induced by
either phosphoinositide 3-kinase-dependent or DAG-dependent pathways in
PDGF-stimulated HepG2 cells.
Conclusions: We conclude that PDGF activates PKCs at two distinct times
and that these two intervals of PKC activity make unequal contributions to the
mitogenic response. The late phase of PKC activity is required for PDGF-dependent
DNA synthesis, whereas the early phase of activity is dispensable. 
Background
In order to progress into S phase, serum-starved cells
require continual exposure to growth factor for about
8–12 hours [1]. This raises the possibility that growth
factors initiate signaling events beyond the commonly
studied early time points (0–60 minutes). Indeed, micro-
injection of reagents that block Ras or phosphoinositide
3-kinase (PI 3-kinase) inhibit entry into S phase even
when the injection is performed 4–6 hours after addition
of growth factor [2,3]. Direct evidence that growth factors
induce signaling events beyond the 60 minute interval
includes the finding that Ras and PI 3-kinase are activated
4 or more hours after stimulation [4,5]. These data show
that growth factors initiate signaling events even after the
early time points, and these late events play a key role in
the transition into S phase.
In multiple cell systems, phospholipase Cγ (PLCγ) plays a
role in platelet-derived growth factor (PDGF)-dependent
DNA synthesis [6,7], suggesting that the members of the
protein kinase C (PKC) family that are responsive to DAG
contribute to mitogenic signaling. Recent work by Wang
et al. [8] showed that DAG was able to rescue DNA syn-
thesis dependent on epidermal growth factor or platelet-
derived growth factor (PDGF) when this response was
blocked by injection of a combination of the Src homology
domains (SH2–SH2–SH3) of PLCγ. These experiments
indicate that DAG-responsive PKC family members are
downstream of PLCγ in the mitogenic cascade initiated by
growth factors; the time at which DAG is required for
DNA synthesis has not been determined, however. 
The PKCs are a large family of serine/threonine kinases
that includes at least 11 members. On the basis of their
structure and biochemical properties, they can be divided
into three groups: conventional PKC (cPKCs) α, βI, βII
and γ; novel PKC (nPKCs) δ, ε, η, θ and µ; and atypical
PKC (aPKCs) ζ and γ. The activity of all PKC family
members depends on phosphatidylserine, but requires
different activators [9,10]. The cPKCs are activated in a
DAG- and calcium-dependent manner; nPKC activity is
DAG-dependent but calcium-independent [9,10]; aPKCs
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do not respond to DAG or calcium, but are activated by
other lipids, such as phosphatidylinositol-3,4,5-triphos-
phate (PtdIns-3,4,5-P3) [11,12]. At least one novel PKC
subfamily member PKCε is activated by both DAG and PI
3-kinase lipid product PtdIns-3,4,5-P3 [10]. This suggests
that PKCε may be an integrator of PLCγ and PI 3-kinase
mitogenic signaling pathways.
Here, we investigated whether, and when, DAG-respon-
sive PKCs contribute to PDGF-dependent DNA synthe-
sis. We focused on DAG-dependent PKCs and found that
they were activated early and then later (4–9 hours) in
PDGF-stimulated cells. We also find that the later phase
of PKCs activity was required for entry into S phase. In
addition, DAG-dependent PKCs were not essential for
the PI 3-kinase-dependent mitogenic signaling, even
though at least one PKC in this group (PKCε) was acti-
vated by the PI 3-kinase-dependent pathway.
Results
DAG rescues PDGF-dependent DNA synthesis in cells
expressing the F5 βPDGFRs
In the experiments described here, we used HepG2 cells
expressing wild type, Y40/51 or F5 PDGF β receptors
(βPDGFRs). The F5 mutant receptor is unable to recruit
PI 3-kinase, Ras GTPase activating protein, the protein
tyrosine phosphatase SHP-2, and PLCγ, and in multiple
cell types fails to initiate DNA synthesis [7]. The Y40/51
βPDGFR has restored binding sites for PI 3-kinase
(tyrosines 740 and 751). In this system, restoration of
tyrosines required for association of PI 3-kinase or PLCγ
rescued the majority of the DNA synthesis response, indi-
cating that PI 3-kinase and PLCγ play an important role in
PDGF-dependent mitogenic signaling [7].
We tested whether and when exogenously added DAG
rescues PDGF-dependent DNA synthesis in HepG2 cells
expressing F5 βPDGFRs. As shown in Figure 1a, addition
of only PDGF or DAG did not stimulate DNA synthesis.
DNA synthesis was induced by addition of both PDGF
and DAG, provided that the DAG was added 6–7 hours
after PDGF. Adding the DAG at earlier or later times was
less effective or completely ineffective (Figure 1a and
data not shown). DAG alone failed to induce the DNA-
synthesis response, regardless of when it was added.
These findings suggest that DAG contributes to PDGF-
dependent cell cycle progression, and that the critical time
of action is 6–7 hours after PDGF stimulation. The reason
why the late requirement for DAG is not satisfied by early
addition of DAG may be due to the rapid metabolism of
DAG. We found that when the dose of DAG was
increased to 200 µg/ml, it rescued PDGF-dependent
DNA synthesis even when DAG was added simultane-
ously with PDGF (data not shown).
If DAG is making a contribution to PDGF-dependent cell
cycle progression at 6–7 hours post PDGF, then its levels
should be elevated at this time point. To test this hypoth-
esis, we determined when PDGF triggers an accumulation
of DAG in HepG2 cells expressing wild-type βPDGFRs.
As shown in Figure 1b, PDGF triggered an increase in the
cellular level of DAG, which remained elevated for at
least 7 hours. The decrease at the 2 hours time point was a
reproducible trend. These results show that PDGF trig-
gered a prolonged increase in the cellular level of DAG.
Importantly, DAG was elevated at the times when exoge-
nously-added DAG rescued PDGF-dependent DNA syn-
thesis. The earlier increase in DAG may be required for
PDGF-stimulated events other than DNA synthesis.
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Figure 1
PDGF increases the level of DAG, which
contributes to PDGF-dependent DNA
synthesis. (a) DAG rescues PDGF-dependent
DNA synthesis. Quiescent HepG2 cells
expressing F5 βPDGFRs were exposed to
10% FBS, 50 ng/ml PDGF or buffer (left
panel). In the right panel cells were stimulated
with 50 ng/ml PDGF, and 100 µg/ml DAG
was added to the cells either simultaneously
with PDGF or 7 h later. Alternatively, the cells
were treated with 100 µg/ml DAG alone. After
18 h, the cells were pulsed with [3H]thymidine
for 4 h, lysed in 0.25 N NaOH and
[3H]thymidine incorporation was measured by
scintillation counting. (b) PDGF-dependent
accumulation of DAG. Quiescent HepG2
cells expressing wild-type βPDGFRs were
stimulated with 50 ng/ml PDGF for the
indicated period of time. Cells were scraped,
total lipids were extracted with chloroform and
the extracted DAG was phosphorylated with
the non-specific bacterial DAG kinase in the
presence of [γ-32P]ATP. The resulting
[32P]phosphatidic acid was separated by
thin-layer chromatography and incorporated
radioactivity quantitated. The data are
presented as the fold induction in thymidine
incorporation compared with buffer-treated
control cells. Each bar represents the
mean ± standard deviation of three
determinations. Similar results were obtained
in three independent experiments.
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PDGF activates PKCs at two distinct time points
DAG is a potent physiological activator of some PKC
family members. HepG2 cells express at least four iso-
forms of the PKC family [13] and three of them, PKCα,
PKCβII and PKCε, are activated by DAG. We focused on
the kinetics of PDGF-dependent PKCε activity, because
activation of PKCε requires DAG and is calcium-indepen-
dent. Figure 2a shows that PDGF increased PKCε activity
at two distinct time points, 10 minutes after PDGF stimu-
lation and then 5–9 hours later. The first phase of PKCε
activity was transient, whereas the second phase of activity
was sustained. PKCε activity in HepG2 cells expressing
F5 βPDGFRs was also investigated. Unlike the wild-type
βPDGFR, the F5 receptor failed to activate PKCε at all
time points tested (Figure 2b). 
As PKCε can be activated by PtdIns-3,4,5-P3 [12], it may
be contributing to activation of PKCε at late time points.
In fact, PtdIns-3,4,5-P3 levels are elevated 3–7 hours after
PDGF stimulation in HepG2 cells [4]. To test whether
there was a requirement for PI 3-kinase in PDGF-depen-
dent activation of PKCε, we determined whether block-
ing PI 3-kinase activity would attenuate PKCε activation.
As shown in Figure 2c, treatment of cells with 100 nM
wortmannin modestly reduced the late phase of PKCε
activity. In these cells, 100 nM wortmannin effectively
blocks PDGF-dependent accumulation of PI 3-kinase
products [14]. These findings indicate that PI 3-kinase
does not play a crucial role in activation of PKCε,
although it does seem to enhance activation at the late
time points (Figure 2c).
The kinetics of PDGF-dependent activation of the other
PKC family members was also determined. The cPKCs
were immunoprecipitated using an antibody that recog-
nizes all members of the cPKC subfamily and the activity
was determined using an in vitro kinase assay. Like PKCε,
at least some cPKC subfamily members were transiently
activated within 10 minutes of exposure to PDGF, and a
prolonged phase of increased activity was detected
4–8 hours later (data not shown). Thus, multiple PKC
family members, representing at least two of the PKC
subfamilies, were activated at two distinct time points in
PDGF stimulated HepG2 cells.
The late phase of PKC activity is required for PDGF-
dependent DNA synthesis
The data presented thus far demonstrate that the DNA
synthesis response could be rescued when DAG was
added 7 hours after PDGF stimulation in HepG2 cells
expressing F5 βPDGFRs (Figure 1a), and that PKCε was
activated 5–9 hours after exposure to PDGF in HepG2
cells expressing wild-type βPDGFRs (Figure 2a). This
suggests that the late phase of PKC activity is involved in
PDGF-dependent DNA synthesis. If this is the case, then
DAG should be activating PKCs when it is added to the
rescue assay described in Figure 1. To test this idea,
PKCε activity was determined under the conditions used
in the DAG rescue assay. Figure 3 shows that the combi-
nation of DAG and PDGF activated PKCε in HepG2 cells
expressing F5 βPDGFRs, almost to the same extent
induced by PDGF in cells expressing wild-type
βPDGFRs. Thus the combination of PDGF and DAG
activates PKCε in HepG2 cells expressing the F5
βPDGFR at the same times that PDGF induces PKCε
activity in HepG2 cells expressing wild-type βPDGFRs.
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Figure 2
PDGF-dependent activation of PKCε. Quiescent HepG2 cells expressing
(a,c) wild-type (WT), (b) F5 or (d) Y40/51 βPDGFRs were stimulated
with 50 ng/ml PDGF for the indicated period of time. Cells were lysed,
PKCε was immunoprecipitated and subjected to an in vitro kinase assay
using a PKC-selective synthetic peptide (Ac-FKKSFKL-NH2 in the
single-letter amino acid code; Ac, acetyl) as a substrate as previously
described [25]. PKCε activity was assayed with or without 150 µg
phosphatidylserine (PS) and 5 µg DAG; the presence of the lipids did
not influence the kinase activity of PKCε, and the data presented here
were obtained in the absence of PS and DAG. In (c), cells were treated
with 100 nM wortmannin 2 h 50 min after PDGF stimulation and 50 nM
wortmannin was added again at the 4 h 50 min time point. These times
were chosen to accommodate the half-life of wortmannin (2 h) as well as
the timing of the second wave of accumulation of PI 3-kinase products
(3–7 h) [2]. The reactions were terminated and then spotted onto P81
paper and washed, and the amount of radioactivity was determined by
scintillation counting. The data are presented as the fold increase
compared with buffer-treated control cells. The average of three
experiments is shown, and the error bars represents standard error of
the mean. The bottom portion of each panel is a western blot of the
PKCε immunoprecipitate that was used in the kinase assay. 
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This finding suggests that DAG mediates PDGF-depen-
dent DNA synthesis via activation of PKCs, including PKCε.
An additional approach to test whether, and when, PKCs
are required for PDGF-dependent DNA synthesis involved
the use of PKC inhibitors. The three PKC inhibitors chosen
inhibit DAG-responsive PKCs but not the other family
members. Each of these inhibitors was tested for their effect
on PDGF-dependent DNA synthesis in cells expressing
wild-type βPDGFs. Figure 4 shows that PDGF-dependent
DNA synthesis was attenuated by 60–80% by each of three
PKC inhibitors. This effect was observed when the inhibitors
were added either 10 minutes before or 7 hours after PDGF.
Inhibition of the DNA-synthesis response by adding the
inhibitors late indicated that there is a late requirement for
PKC activity. It is likely that the cells pretreated with the
inhibitor failed to respond to PDGF because the inhibitors
have a long enough half-life to block the late phase of PKC
activity. However, this particular experimental approach
did not rule out the possibility that the initial activation of
PKC is required for subsequent DNA synthesis.
To explore whether the early burst of PKC activity is
required for DNA synthesis we used an inhibitor-washout
strategy. At least one of these inhibitors is known to be
reversible [15]. Figure 4 shows that removing the PKC
inhibitors after 1 hour largely reversed the inhibitory
effects on PDGF-dependent DNA synthesis. This was
true for two of the three PKC inhibitors, whereas the
1-O-hexadecyl-2-O-acetyl-sn-glycerol-treated culture did
not fully recover, perhaps due to incomplete removal of
the inhibitor. These results indicate that the early phase
of PKC activity is dispensable for the entry into S phase,
whereas the late phase of PKC activity was essential for
the PDGF-dependent mitogenic response. 
PKCε does not make a major contribution to the
PI 3-kinase-dependent mitogenic signaling
We have previously found that PI 3-kinase products accu-
mulate in PDGF-stimulated cells at two times, immedi-
ately after stimulation and then 3–7 hours later; the latter
time at least in part overlaps with the second phase of
PKCε activity. Furthermore, the late wave of PI 3-kinase
activity was required for PDGF-dependent DNA synthe-
sis [4]. These findings, together with the observation that
the late wave of PKCε activity was contributing to S phase
entry (Figure 4), suggested that PKCε may be an essential
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Figure 3
DAG activates PKCε in the conditions used in the DAG rescue assay.
Quiescent HepG2 cells expressing F5 βPDGFRs were stimulated with
50 ng/ml PDGF, and 100 µg/ml DAG was added either simultaneously
with PDGF or 7 h later. Cells were lysed 10 min after the addition of
DAG and PKCε immunoprecipitated. PKCε activity was determined as
described in the legend of Figure 2. The data presented are the fold
increase compared with buffer-treated control cells. The average of
three independent experiments is shown, and the error bars represents
standard error of the mean. These findings indicate that PKCε was
activated by the exogenously added DAG at either time point. Note
that cells were driven into S phase only when DAG was added at the
late time point (Figure 1a).
Figure 4
PKC inhibitors block PDGF-induced DNA synthesis. Quiescent HepG2
cells expressing wild-type βPDGFRs were stimulated with 10% FBS or
50 ng/ml PDGF or exposed to buffer in the control group (left panel).
The samples in the right panel were treated in one of the three ways. In
the left group, the cells were pretreated for 10 min with 20 µM
1-O-hexadecyl-2-O-acetyl-sn-glycerol, 50 µM calphostin C, or 20 nM
bisindolylmaleimide I, then 50 ng/ml PDGF was added. In the middle
group, PDGF was added first and inhibitors were added 7 h later. In the
right group, inhibitors were added 10 min before PDGF and removed
by washing 1 h after PDGF. The incubation was continued in the media
containing 50 ng/ml PDGF or buffer. After a total of 18 h, the cells were
pulsed with [3H]thymidine for 4 h, lysed in 0.25 N NaOH and
[3H]thymidine incorporation was measured by scintillation counting. The
data are presented as the fold induction of thymidine incorporation
compared with buffer-treated control cells. Each bar represents the
mean ± standard deviation of three determinations. Similar results were
obtained in three independent experiments.
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component of the PI 3-kinase-dependent mitogenic
pathway. To investigate this possibility, we tested
whether blocking PKCs would prevent PI 3-kinase-
dependent entry into S phase. The first approach was to
use the Y40/51 receptor, which activates the PI 3-kinase
pathway, but not the PLCγ pathway. As predicted, this
receptor was able to trigger activation of PKCε
(Figure 2d), yet two different PKC inhibitors had little
effect on PDGF-dependent DNA synthesis in cells
expressing this receptor (Figure 5a). The second approach
was to use the PI 3-kinase lipid rescue assay [4], which is
similar to the DAG rescue assay described in Figure 1,
except PI 3-kinase lipid products are used instead of
DAG. As with the first approach, we found that the PKC
inhibitors were not able to potently inhibit DNA synthesis
(Figure 5b). Finally, Figure 5c shows that the PKC
inhibitors were specific, as they were unable to block PI
3-kinase-dependent phosphorylation of Akt. We conclude
that, although engagement of PI 3-kinase does activate
PKCε, it does not appear to be making an essential contri-
bution to the PI 3-kinase-dependent mitogenic pathway.
Discussion
In the continuous presence of PDGF, PKCε activity
increased quickly (at 10 minutes) then receded and grad-
ually increased a second time for a much longer duration
(5–9 hours; Figure 2a). These observations raise the
question of what is regulating the activity of PKCs.
There are two aspects of PKC regulation, lipid co-factors
and phosphorylation of PKCs by other kinases such as
3-phosphoinositide-dependent protein kinase (PDK-1) [16].
Both DAG and PtdIns-3,4,5-P3 have been shown to con-
tribute to activation of PKCε [10]. Changes in the level of
DAG do not adequately explain the changes in PKCε
activity. We and others [17] have found that the level of
DAG increases and remains elevated in PDGF-stimulated
cells, but the activity of PKCε rises and falls within this
time interval. Although it is likely that the increase in
DAG is contributing to PKCε activation, it does not fully
explain how PKCε is activated. Similarly, changes in
PtdIns-3,4,5-P3 levels did not correspond to the observed
fluctuation in PKCε activity, and blocking PI 3-kinase
activity did not eliminate PDGF-dependent activation of
PKCε (Figure 2c). Thus, neither of the lipid co-factors
appear fully responsible for the changes in PKCε activity.
Perhaps the input from other kinases, such as PDK-1,
make an important contribution to PKCε activation.
PLCγ could be participating in the regulation of PKCε
activity, but perhaps not through its lipase activity.
Microinjection of catalytic-defective PLCγ into NIH 3T3
cells only partially inhibits DNA synthesis, whereas com-
plete inhibition is obtained by microinjection of antibodies
that interact with the PLCγ noncatalytic domain [6]. This
observation suggests that the noncatalytic domain of PLCγ
is critical for PLCγ mitogenic signaling. PLCγ activity per-
sisted up to two hours after PDGF stimulation, but tyro-
sine phosphorylation and association with the βPDGFR
Research Paper  Two phases of PKC activity Balciunaite et al. 265
Figure 5
PKC inhibitors do not block PI 3-kinase-mediated DNA synthesis.
(a) PKC inhibitors did not block PDGF-dependent DNA synthesis in
HepG2 cells expressing Y40/51 βPDGFRs. Serum-arrested HepG2
cells expressing Y40/51 βPDGFRs were left resting (–) or exposed to
50 ng/ml PDGF (+). After 5 h, buffer, 50 µM calphostin C (Cal) or 20 nM
bisindolylmaleimide I (BIM) was added. The cells were then pulsed with
[3H]thymidine and the extent of incorporation determined as in Figure 4.
The results from the experiments where PKC inhibitors were added at
different times were indistinguishable. (b) PKC inhibitors did not block
phosphatidylinositol-dependent DNA synthesis. Serum-starved HepG2
cells expressing F5 βPDGFRs were treated as follows. In the left panel,
cells were exposed to buffer, or 10% FBS. In the right panel all cells
received PDGF (50 ng/ml), and 6 h later 25 µM PtdIns-3,4-P2 and
PtdIns-3,4,5-P3 were added to the indicated samples. In the addition,
some cultures were treated with 50 nM calphostin C, 20 nM
bisindolylmaleimide or buffer 10 min before adding the PtdIns lipids. The
cells were subsequently pulsed with [3H]thymidine and harvested as
described in Figure 4. (c) PKC inhibitors do not block Akt
phosphorylation. Quiescent HepG2 cells expressing wild-type
βPDGFRs were stimulated with 50 ng/ml PDGF for 5 h or left resting as
indicated. Buffer (B), 50 nM calphostin C or 20 nM bisindolylmaleimide I
were added 2 h 50 min after PDGF. After 5 h, cells were lysed, 50 ng of
total protein were separated by SDS–PAGE, transferred onto Immobilon
and subjected to western blot analysis using anti-Akt and anti-phospho-
Akt (P-Akt) antibodies. The graph represents the ratio of Akt
phosphorylation intensity to Akt protein level.
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lasts for at least 8 hours in HepG2 cells (data not shown).
This observation raises a question about the role of PLCγ
in the late activation of PKCs. Perhaps PLCγ participates
in the induction of the late phase of PKCε activity, but not
through its enzymatic activity. The role of PLCγ in the late
phase of PKC activity is being further investigated.
Our findings have begun to address the importance of
cross-talk between the PI 3-kinase and PLCγ pathways.
At the level of enzyme activation, there are several ways in
which PI 3-kinase contributes to PKC-dependent activa-
tion. In certain settings, PI 3-kinase lipids recruit PLCγ to
the membrane and promote its activation [18–20]. Simi-
larly, PI 3-kinase products recruit PDK-1 to the mem-
brane, and PDK-1 phosphorylates some PKC family
members on the activation loop [16]. PI 3-kinase products
also act as lipid co-factors for certain PKCs [12]. Despite
the ability of the PI 3-kinase pathway to promote activa-
tion of PKCε, this does not translate to cellular responses
such as cell cycle progression. Blocking conventional and
novel PKCs failed to markedly attenuate the PI3K-depen-
dent entry into S phase (Figure 5). These studies indicate
that neither PKCε nor other DAG-dependent PKCs
serves as a convergence point for PI 3-kinase in the PKC-
dependent mitogenic cascades. Although our studies do
not rule out the existence of cross-talk between the PI
3-kinase and PLCγ pathways during mitogenic signaling,
we could not find a step that requires such an interaction.
Perhaps the ability of these two signaling systems to inter-
face is more important in other cellular responses. 
We found that the first, transient burst of PKC activity is
dispensable for PDGF-dependent DNA synthesis and that
PKCs make an important contribution at the latter time
points. Consequently, the PDGF-dependent transition into
S phase appears to proceed unimpeded when at least some
of the PKCs are not activated. It is possible that the early
PKC requirement [21,22] is compensated for by one of the
numerous other signaling cascades initiated by PDGF. In
contrast, further progression into the S phase requires PKC
activity. Perhaps the requirement for PKCs relates to its
ability to modulate levels of the cyclin-dependent kinase
inhibitor p27Kip1 and/or phosphorylate retinoblastoma, as
has been previously reported [23,24]. Our future studies
will be focused on further investigation of these questions.
Conclusions
We conclude that, in response to PDGF, PKCε and at
least some of the conventional PKC family members are
activated at two distinct time points. The second phase of
PKCs activity is required for S phase entry, but the first
phase is dispensable. In addition, our studies indicate that
PKCε can be activated by either the PI 3-kinase-depen-
dent or the DAG-dependent pathway, but PKCε does not
make a major contribution to the PI 3-kinase-dependent
mitogenic signaling. 
Materials and methods 
HepG2 cells expressing wild-type or F5 βPDGFRs were previously
described [7]. Cells were maintained in Dulbecco’s modified Eagles’s
medium (DMEM) supplemented with 10% fetal bovine serum (FBS).
Polyclonal antibodies against PKCε were obtained from Santa Cruz. For
western blots, antibodies were used at a 1:500 dilution. Peroxidase-con-
jugated goat anti-rabbit and goat anti-mouse antibodies were purchased
from Calbiochem and were used at a 1:5000 dilution. Calphostin C and
bisindolylmaleimide I were purchased from Calbiochem, 1-O-Hexadecyl-
2-O-acetyl-sn-glycerol was purchased from BioMol, PDGF-BB was gen-
erously provided by Amgen, 1,2-di-octanoyl-sn-glycerol (DAG) was
obtained from Avanti Polar Lipids, the PKC-selective synthetic peptide
(Ac-FKKSFKL-NH2) used in PKC kinase assay was described in [25],
wortmannin was purchased from Sigma, and PtdIns-3,4-P2 and PtdIns-
3,4,5-P3 were obtained from Echelon Research Laboratories.
[3H]thymidine incorporation
[3H]thymidine incorporation was done as previously described [7] with
some modifications. HepG2 cells expressing F5 or wild-type βPDGFRs
were plated in 24-well plates at a density of 5 × 104 cells per well in
DMEM plus 10% FBS for 24 h. The cells were washed twice with PBS
and DMEM supplemented with 0.2% FBS was added for 48 h. The
cells were then stimulated with 50 ng/ml PDGF or 10% FBS. PDGF
buffer (10 mM acetic acid and 2 mg/ml bovine serum albumin) or
dimethylsulfoxide (DMSO) was added to the media of control cells.
DAG or PKC inhibitors (stock solutions prepared in DMSO) were
added at the indicated times and concentrations. The cultures were
incubated for 18 h and then pulsed with 0.8 µCi/ml [3H]thymidine in
DMEM plus 5% FBS for 4 h. Cells were washed first with ice-cold
PBS, then with 5% trichloroacetic acid and lysed in 0.25 N NaOH.
Lysates were transferred into scintillation vials containing 50 µl of 6 N
HCl and 4 ml of scintillation cocktail (ICN). The incorporated radioactiv-
ity was determined by liquid scintillation counting.
Immunoprecipitation
Immunoprecipitation of βPDGFRs was done as previously described [26].
Subconfluent HepG2 cells expressing wild-type βPDGFRs were serum
starved in DMEM plus 0.2% FBS at 37°C in 5% CO2 for 30 h. PDGF
or PDGF buffer were added into the media and incubation was contin-
ued for the indicated time. Cells were washed twice with ice-cold wash
buffer (20 mM HEPES pH 7.4, 150 mM NaCl) and lysed in lysis buffer
(10 mM Tris–HCl pH 7.4, 5 mM EDTA, 150 mM NaCl, 50 mM NaF, 1%
Triton X-100, 20 µg/ml aprotinin, 1 mM phenylmethylsulfonyl fluoride,
1 mM sodium orthovanadate and 10% glycerol). The lysates were cen-
trifuged at 13,000 × g for 15 min at 4°C and the protein concentration
of the clarified lysates was determined using the bicinchoninic acid
protein assay (Pierce).
Antibodies against PKCε or cPKCs were added to 1 mg of cell lysates.
The immune complexes were bound to formalin-fixed membranes of
Staphylococcus aureus, spun through lysis buffer plus 10% sucrose,
washed twice with wash buffer (10 mM PIPES pH 7.0, 100 mM NaCl,
20 µg/ml aprotinin) plus 0.5% Nonidet P-40 plus 0.5 M LiCl, twice with
wash buffer plus 0.5 M NaCl and twice with wash buffer. Immunopre-
cipitates were resuspended in 30 µl of wash buffer and used immedi-
ately or stored at –70°C.
DAG assay
HepG2 cells expressing wild-type βPDGFRs were plated in 100 mm
dishes and incubated at 37°C for 24 h and serum-starved in DMEM plus
0.2% FBS. After 30 h the cells were stimulated with PDGF for the indi-
cated period of time. The incubation was terminated by removing the
medium and adding 2 ml ice-cold methanol/0.1 N HCl (1:1). The cells
were scraped and lipids were extracted with 1 ml chloroform. The amount
of DAG in the chloroform fraction was measured by using a DAG assay
kit (Amersham). A 200 µl aliquot of the chloroform fraction was used per
reaction. DAG in the sample was converted to phosphatidic acid using
bacterial DAG kinase in the presence of [γ-32P]ATP. The resulting
[32P]phosphatidic acid was separated by thin-layer chromatography
266 Current Biology Vol 10 No 5
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on Silicia gel 60 A plates (Whatman). The amount of radiolabeled
phosphatidic acid was quantitated using a PhosphoImager (BioRad).
PKC kinase assay
The PKC kinase assays were performed as described [25] with some
modifications. Briefly, PKC immunoprecipitate (100% of a subconfluent
100 mm dish) was incubated with 150 nM of PKC-selective synthetic
peptide (Ac-FKKSFKL-NH2) in kinase buffer (10 mM HEPES, 1 mM
DTT, 5 µCi [γ-32P]ATP, 10 µM ATP, 10 mM MnCl2) in the presence or
absence of 150 µM phosphatidylserine and 5 µM DAG for 10 min at
25°C in a final volume of 80 µM. The reaction was stopped by centrifu-
gation at 3000 × g for 5 min, which separated the immobilized PKC
immunoprecipitates from the soluble substrate. The supernatant from
each of the samples was spotted onto P81 ion-exchange chromatogra-
phy paper, washed 4 times with 1% phosphoric acid and the incorpo-
ration of 32P into peptide was detected by liquid scintillation counting.
Lipid rescue assay
The PI 3-kinase lipid rescue assay was performed as previously
described [4]. HepG2 cells expressing F5 βPDGFRs were plated in
DMEM supplemented with 10% FBS at a density of 4 × 104 cells per well
in 24-well plate for 24 h. The cells were washed twice with 1 ml PBS and
incubated in DMEM supplemented with 0.2% FBS for 48 h. The cells
were stimulated with 50 ng/ml PDGF, PDGF buffer or 10% FBS. Some
of the cultures were treated with either calphostin C (50 nM) or bisindolyl-
maleimide I (20 nM) at 5 h 50 min post PDGF stimulation. Some of the
cultures were also given 25 µM each PtdIns-3,4-P2 and PtdIns-3,4,5-P3
at 6 h post PDGF. For these samples, the stimulation medium was
removed and replaced with permeabilization buffer (100 µl PBS contain-
ing 0.05 mg/ml saponin) as well as the lipids. The permeabilization and
lipid administration was performed at 25°C for 10 min. For these samples,
the stimulation media was reserved during the lipid addition and added
back to their respective cultures after lipid administration. The incubation
was continued for 12 h and after that cells were pulsed with [3H]thymi-
dine. The incorporated [3H]thymidine was measured as described above.
Western blotting analysis
Immunoprecipitates were boiled at 95°C in SDS–PAGE buffer
(200 mM Tris–HCl pH 6.8, 10 mM EDTA, 4% SDS, 5.6 M β-mercap-
toethanol, 20% glycerol, 0.2% bromophenol blue) for 4 min, resolved
on a 10% SDS–PAGE gel and transferred onto Immobilon (Millipore).
Membranes were blocked with TBST (10 mM Tris base pH 8.0;
150 mM NaCl, 0.2% Tween-20) plus 5% nonfat dry milk for 1 h,
probed with primary antibodies, washed with rinse buffer (10 mM Tris
base pH 7.5, 150 mM NaCl) and probed with peroxidase-conjugated
secondary antibodies. Proteins were detected using enhanced chemi-
luminescence (Amersham Pharmacia Biotech).
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